And the risk is reflected in the share price. Is it not?
Imo there’s 5-10 bags on offer over the next couple of years. People can be “antsy” all they want, if they don’t like the opportunity, then there are 2000 other options.
As for “there is an actual risk specs can go under”, yeah that’s a point, but imo a point more relevant to companies that that are nowhere near production; we aren’t a bunch of hopefuls sitting around the office trying to get someone interested in funding so we can get an operation going.
We are in a very very different situation than a typical “spec” company trying to progress to actually developing a project.
It’s entirely possible, afaict, that if we can get our current plant humming along near capacity we could be self-sustaining ….and that could happen over the next say 6-12 months imo.
So at this stage, imo it’s quite absurd to be entertaining the idea that we could “go under”, despite the delays we have had with commissioning the plant.
I’m still buying more, as IMO the risk is hugely asymmetrical at this level.
Is there risk? Of course there is, but nowhere near as much as there would be if we were in the position of a typical “spec” co.
This narrative that some (others) are pushing, that the company is not doing things that they “obviously” should be doing, is pure disgruntled rubbish imo, spoken mostly by those who have probably never stepped foot on an operation anything like this.
I note; again, that those same posters avoid analysis of risk-reward like the plague.
In the meantime, we wait.
ATL looking under the hood and committing $5M to enable offtake (afaict) is nothing but absolutely positive. Does anyone here actually believe they haven’t asked Puna the tough questions…?
Imo
Dyor
- Forums
- ASX - By Stock
- General Discussion AGY
And the risk is reflected in the share price. Is it not? Imo...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $125.2M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $320.1K | 3.590M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 510849 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 15519 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 512067 | 0.085 |
4 | 219873 | 0.084 |
3 | 157062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 15519 | 5 |
0.087 | 23085 | 4 |
0.088 | 266445 | 2 |
0.089 | 82187 | 6 |
0.090 | 32344 | 1 |
Last trade - 14.35pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online